85 related articles for article (PubMed ID: 1987788)
1. Distinct but nonadditive effects of epinephrine and cortisol on determinants of glucose tolerance in dogs.
Martin IK; Christopher MJ; Alford FP; Best JD
Am J Physiol; 1991 Jan; 260(1 Pt 1):E148-53. PubMed ID: 1987788
[TBL] [Abstract][Full Text] [Related]
2. Effects of acute and chronic counterregulatory hormone infusions on glucose tolerance and insulin sensitivity in diabetic dogs.
Sleeman MW; Christopher MJ; Martin IK; Ward GM; Alford FP; Best JD
Diabetes; 1992 Nov; 41(11):1446-52. PubMed ID: 1397720
[TBL] [Abstract][Full Text] [Related]
3. Effects of epinephrine infusion on determinants of intravenous glucose tolerance in dogs.
Martin IK; Weber KM; Boston RC; Alford FP; Best JD
Am J Physiol; 1988 Nov; 255(5 Pt 1):E668-73. PubMed ID: 3056033
[TBL] [Abstract][Full Text] [Related]
4. Effects of an acute increase in epinephrine and cortisol on carbohydrate metabolism during insulin deficiency.
Goldstein RE; Abumrad NN; Lacy DB; Wasserman DH; Cherrington AD
Diabetes; 1995 Jun; 44(6):672-81. PubMed ID: 7789632
[TBL] [Abstract][Full Text] [Related]
5. Role of epinephrine and norepinephrine in the metabolic response to stress hormone infusion in the conscious dog.
McGuinness OP; Shau V; Benson EM; Lewis M; Snowden RT; Greene JE; Neal DW; Cherrington AD
Am J Physiol; 1997 Oct; 273(4):E674-81. PubMed ID: 9357794
[TBL] [Abstract][Full Text] [Related]
6. Interaction of free fatty acids and epinephrine in regulating hepatic glucose production in conscious dogs.
Chu CA; Galassetti P; Igawa K; Sindelar DK; Neal DW; Burish M; Cherrington AD
Am J Physiol Endocrinol Metab; 2003 Feb; 284(2):E291-301. PubMed ID: 12531743
[TBL] [Abstract][Full Text] [Related]
7. Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog: a model for stress-induced hyperglycemia.
Eigler N; Saccà L; Sherwin RS
J Clin Invest; 1979 Jan; 63(1):114-23. PubMed ID: 762240
[TBL] [Abstract][Full Text] [Related]
8. Epinephrine effects on insulin-glucose dynamics: the labeled IVGTT two-compartment minimal model approach.
Vicini P; Avogaro A; Spilker ME; Gallo A; Cobelli C
Am J Physiol Endocrinol Metab; 2002 Jul; 283(1):E78-84. PubMed ID: 12067846
[TBL] [Abstract][Full Text] [Related]
9. Epinephrine exerts opposite effects on peripheral glucose disposal and glucose-stimulated insulin secretion. A stable label intravenous glucose tolerance test minimal model study.
Avogaro A; Toffolo G; Valerio A; Cobelli C
Diabetes; 1996 Oct; 45(10):1373-8. PubMed ID: 8826974
[TBL] [Abstract][Full Text] [Related]
10. The effect of epinephrine on glucose-mediated and insulin-mediated glucose disposal in insulin-dependent diabetes.
Walters JM; Ward GM; Kalfas A; Best JD; Alford FP
Metabolism; 1992 Jun; 41(6):671-7. PubMed ID: 1640854
[TBL] [Abstract][Full Text] [Related]
11. Effects of epinephrine on insulin secretion and action in humans. Interaction with aging.
Morrow LA; Morganroth GS; Herman WH; Bergman RN; Halter JB
Diabetes; 1993 Feb; 42(2):307-15. PubMed ID: 8425666
[TBL] [Abstract][Full Text] [Related]
12. Contrasting action of short- and long-term adrenaline infusion on dog skeletal muscle glucose metabolism.
Christopher MJ; Sleeman MW; Alford FP; Best JD
Diabetologia; 1992 May; 35(5):399-405. PubMed ID: 1387857
[TBL] [Abstract][Full Text] [Related]
13. Glucoregulatory role of cortisol and epinephrine interactions studied in adrenalectomized dogs.
Gauthier C; el-Tayeb K; Vranic M; Lickley HL
Am J Physiol; 1986 Apr; 250(4 Pt 1):E393-401. PubMed ID: 3515964
[TBL] [Abstract][Full Text] [Related]
14. Differing physiological effects of epinephrine in type 1 diabetes and nondiabetic humans.
Guy DA; Sandoval D; Richardson MA; Tate D; Flakoll PJ; Davis SN
Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E178-86. PubMed ID: 15585598
[TBL] [Abstract][Full Text] [Related]
15. RU 486 prevents the acute effects of cortisol on glucose and leucine metabolism.
Garrel DR; Moussali R; De Oliveira A; Lesiège D; Larivière F
J Clin Endocrinol Metab; 1995 Feb; 80(2):379-85. PubMed ID: 7888013
[TBL] [Abstract][Full Text] [Related]
16. Effects of epinephrine on insulin-mediated glucose uptake in whole body and leg muscle in humans: role of blood flow.
Laakso M; Edelman SV; Brechtel G; Baron AD
Am J Physiol; 1992 Aug; 263(2 Pt 1):E199-204. PubMed ID: 1514599
[TBL] [Abstract][Full Text] [Related]
17. In vivo regulation of non-insulin-mediated and insulin-mediated glucose uptake by epinephrine.
Baron AD; Wallace P; Olefsky JM
J Clin Endocrinol Metab; 1987 May; 64(5):889-95. PubMed ID: 2881942
[TBL] [Abstract][Full Text] [Related]
18. Impact of acute epinephrine removal on hepatic glucose metabolism during stress hormone infusion.
McGuinness OP; Snowden RT; Moran C; Neal DW; Fujiwara T; Cherrington AD
Metabolism; 1999 Jul; 48(7):910-4. PubMed ID: 10421235
[TBL] [Abstract][Full Text] [Related]
19. Epinephrine infusion during moderate intensity exercise increases glucose production and uptake.
Kreisman SH; Ah Mew N; Arsenault M; Nessim SJ; Halter JB; Vranic M; Marliss EB
Am J Physiol Endocrinol Metab; 2000 May; 278(5):E949-57. PubMed ID: 10780953
[TBL] [Abstract][Full Text] [Related]
20. The direct effects of catecholamines on hepatic glucose production occur via alpha(1)- and beta(2)-receptors in the dog.
Chu CA; Sindelar DK; Igawa K; Sherck S; Neal DW; Emshwiller M; Cherrington AD
Am J Physiol Endocrinol Metab; 2000 Aug; 279(2):E463-73. PubMed ID: 10913048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
